Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Halothane metabolism in cirrhotic rats.

J M Baden1, M Serra, M Fujinaga

  • 1Department of Anesthesia, Stanford University School of Medicine, California.

Anesthesiology
|November 1, 1987
PubMed
Summary

Halothane anesthesia did not alter its metabolism in cirrhotic rats. However, anesthesia exacerbated liver dysfunction more significantly in cirrhotic rats, suggesting indirect effects rather than toxic metabolites.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges.

Radiation oncology (London, England)·2026
Same author

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

Corrigendum to < 'Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells'> <[Non-coding RNA Research vol. 13 (2025) 153-161]>.

Non-coding RNA research·2026

Area of Science:

  • Anesthesiology
  • Hepatology
  • Toxicology

Background:

  • Cirrhosis can alter drug metabolism and increase susceptibility to liver injury.
  • Halothane is an inhalational anesthetic agent whose metabolism and potential hepatotoxicity are of clinical concern.

Purpose of the Study:

  • To investigate halothane metabolism in a rat model of cirrhosis.
  • To determine if altered metabolism correlates with exacerbated liver dysfunction post-anesthesia.

Main Methods:

  • Cirrhosis was induced in Wistar rats using carbon tetrachloride.
  • Rats underwent halothane anesthesia (1.05% in 50% oxygen for 3 hours).
  • Halothane metabolites (inorganic fluoride, bromide, trifluoroacetic acid) and liver function enzymes (SGOT, SGPT) were monitored.

Related Experiment Videos

Main Results:

  • No significant differences in halothane metabolite levels or excretion were found between cirrhotic and non-cirrhotic rats.
  • Serum SGOT and SGPT levels increased significantly after anesthesia in both groups.
  • The increase in liver enzymes was significantly greater in cirrhotic rats compared to non-cirrhotic rats.

Conclusions:

  • Halothane metabolism is not significantly altered by cirrhosis in this rat model.
  • Exacerbation of liver dysfunction after halothane anesthesia in cirrhosis is likely due to indirect mechanisms, such as altered liver blood flow.
  • Direct toxicity from halothane metabolites does not appear to be the primary driver of increased liver injury in cirrhotic rats.